Extrawell Pharmaceutical Holdings Limited (0858) Stock Statistics & Valuation Metrics

Extrawell Pharmaceutical Holdings Limited has a market cap or net worth of HK$329.82M. The enterprise value is HK$236.84M.

Extrawell Pharmaceutical Holdings Limited has 2,390,000,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Extrawell Pharmaceutical Holdings Limited’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is -0.53%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Extrawell Pharmaceutical Holdings Limited had revenue of 59.10M and earned -162.95M in profits. Earnings per share was -0.07.

In the last 12 months, operating cash flow was 2.81M and capital expenditures -1.20M, giving a free cash flow of 1.61M billion.

Extrawell Pharmaceutical Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Extrawell Pharmaceutical Holdings Limited upcoming earnings date is Nov 28, 2025, TBA (Not Confirmed).

Extrawell Pharmaceutical Holdings Limited as a current ratio of 3.45, with Debt / Equity ratio of 10.70%

In the past 12 months, Extrawell Pharmaceutical Holdings Limited has paid 2.13M in taxes.

Extrawell Pharmaceutical Holdings Limited EV to EBITDA ratio is -0.74, with an EV/FCF ratio of -19.65.

Extrawell Pharmaceutical Holdings Limited has HK$870.44M in cash and marketable securities with HK$130.18M in debt, giving a net cash position of -HK$740.26M billion.

Gross margin is 43.01%, with operating margin of -11.04%, and net profit margin of -275.73%.

The average price target for Extrawell Pharmaceutical Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―